Cyclopharm Limited Stock
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
09:10:16 15/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4200 AUD | -7.69% |
|
-18.45% | -57.14% |
| Market Cap | 52.81M 36.76M 33.05M 30.84M 27.95M 52.48M 3.5B 370M 145M 1.82B 138M 135M 5.84B | P/E 2026 * |
-3.2x | P/E 2027 * | -5.02x |
|---|---|---|---|---|---|
| Enterprise Value | 52.81M 36.76M 33.05M 30.84M 27.95M 52.48M 3.5B 370M 145M 1.82B 138M 135M 5.84B | EV / Sales 2026 * |
1.42x | EV / Sales 2027 * | 1.12x |
| Free-Float |
51.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| 1 day | -7.69% | ||
| 1 week | -18.45% | ||
| Current month | -7.69% | ||
| 1 month | -22.22% | ||
| 3 months | -13.40% | ||
| 6 months | -46.15% | ||
| Current year | -57.14% |
| 1 week | 0.41 |  | 0.49 |
| 1 month | 0.41 | | 0.52 |
| Current year | 0.41 | | 1.29 |
| 1 year | 0.41 | | 1.29 |
| 3 years | 0.41 | | 2.51 |
| 5 years | 0.41 | | 3.15 |
| 10 years | 0.41 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Kevin Barrow
BRD | Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/03/26 | Buy | Director | 21,052 | 0.0175% | ||
| 12/03/26 | Buy | Director | 5,263 | 0.0044% | ||
| 12/03/26 | Buy | Director | 21,052 | 0.0175% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.69% | -18.45% | -27.59% | -82.50% | 39.82M | |
| +2.77% | +5.84% | +30.73% | +41.25% | 249B | |
| +2.76% | +5.80% | +11.63% | +9.32% | 158B | |
| +0.95% | +2.06% | -2.68% | +54.64% | 148B | |
| +2.05% | +4.42% | -55.07% | -12.38% | 62.32B | |
| +1.95% | +6.77% | -13.31% | -14.31% | 49.61B | |
| -0.35% | +2.09% | +17.92% | +20.67% | 49.83B | |
| +5.05% | +9.66% | +8.69% | +47.37% | 48.14B | |
| +0.74% | +4.22% | +25.51% | +57.19% | 49.06B | |
| +1.26% | +2.74% | +32.64% | +72.79% | 42.9B | |
| Average | +0.93% | +0.82% | +2.85% | +19.40% | 85.72B | |
| Weighted average by Cap. | +2.08% | +1.95% | +10.45% | +32.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.2M 25.89M 23.28M 21.73M 19.69M 36.97M 2.46B 261M 102M 1.28B 97.22M 95.11M 4.11B | 47.2M 32.86M 29.54M 27.57M 24.98M 46.91M 3.13B 331M 129M 1.62B 123M 121M 5.22B |
| Net income | -17.4M -12.11M -10.89M -10.16M -9.21M -17.29M -1.15B -122M -47.62M -598M -45.47M -44.49M -1.92B | -12.4M -8.63M -7.76M -7.24M -6.56M -12.32M -821M -86.91M -33.94M -426M -32.41M -31.7M -1.37B |
| Net Debt | - | - |
Employees
104
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | A$0.4200 | -7.69% | 352,617 |
| 14/10/26 | A$0.4550 | 0.00% | 61,773 |
| 13/10/26 | A$0.4550 | -3.19% | 87,010 |
| 12/10/26 | A$0.4700 | +2.17% | 21,035 |
| 09/10/26 | A$0.4600 | -3.16% | 169,702 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3167USD
Average target price
0.7170USD
Spread / Average Target
+126.38%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
